Glycemic Control after Total Pancreatectomy for Intraductal Papillary Mucinous Neoplasm: An Exploratory Study
Table 2
Comparison of HbA1c values after baseline between total pancreatectomy and type I diabetes mellitus patients.
TP-Type I DM
Time after baseline
TP-HbA1c (%)
Type I DM-HbA1c (%)
Single variable analysis
Multivariable analysis
Median (min–max)
Mean ± SD
Median (min–max)
Mean ± SD
Difference in means (95% CI)
value
Difference in means (95% CI)
value
6 months
7.5 (6.5–8.5)
7.5 ± 0.5
10
7.4 (4.7–11.5)
7.7 ± 1.4
100
−0.14 (−1.00, 0.72)
0.74
−0.05 (−1.05, 0.95)
0.93
12 months
7.3 (5.2–8.4)
7.3 ± 1.0
9
8.0 (5.2–11.8)
8.0 ± 1.2
68
−0.69 (−1.54, 0.15)
0.11
−0.67 (−1.57, 0.23)
0.14
18 months
7.8 (6.9–8.3)
7.7 ± 0.5
7
7.6 (5.3–10.3)
7.6 ± 1.0
65
0.11 (−0.69, 0.90)
0.79
−0.05 (−0.94, 0.84)
0.91
24 months
7.3 (6.6–8.1)
7.3 ± 0.6
6
7.8 (5.4–10.9)
7.8 ± 1.2
58
−0.50 (−1.47, 0.48)
0.31
−0.78 (−1.87, 0.31)
0.16
Estimates of differences in means and values result from a two-sample -test. Estimates of differences in means and -values result from linear regression models adjusted for age at baseline, gender, weight, and years of education, all of which differed between TP patients and type I diabetes mellitus patients with a -value of 0.05 or less. (TP: total pancreatectomy; DM: diabetes mellitus).
